ACAD logo

ACADIA Pharmaceuticals (ACAD) Shareholders Equity

Annual Shareholders Equity

$431.75 M
+$31.34 M+7.83%

December 31, 2023


Summary


Performance

ACAD Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherACADbalance sheetmetrics:

Quarterly Shareholders Equity

$577.18 M
+$60.48 M+11.71%

September 30, 2024


Summary


Performance

ACAD Quarterly Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherACADbalance sheetmetrics:

Shareholders Equity Formula

Shareholders Equity = Total Assets − Total Liabilities

ACAD Shareholders Equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+7.8%+59.4%
3 y3 years-31.1%+1.8%
5 y5 years-9.9%-16.3%

ACAD Shareholders Equity Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-20.2%+7.8%at high+59.4%
5 y5-year-38.2%+7.8%-17.4%+59.4%
alltimeall time-38.2%+919.7%-17.4%+1088.1%

ACADIA Pharmaceuticals Shareholders Equity History

DateAnnualQuarterly
Sep 2024
-
$577.18 M(+11.7%)
Jun 2024
-
$516.70 M(+11.3%)
Mar 2024
-
$464.04 M(+7.5%)
Dec 2023
$431.75 M(+7.8%)
$431.75 M(+19.2%)
Sep 2023
-
$362.17 M(-8.5%)
Jun 2023
-
$395.79 M(+5.8%)
Mar 2023
-
$374.26 M(-6.5%)
Dec 2022
$400.41 M(-26.0%)
$400.41 M(-5.9%)
Sep 2022
-
$425.69 M(-2.1%)
Jun 2022
-
$434.85 M(-2.2%)
Mar 2022
-
$444.80 M(-17.8%)
Dec 2021
$540.89 M(-13.7%)
$540.89 M(-4.6%)
Sep 2021
-
$566.96 M(+0.4%)
Jun 2021
-
$564.84 M(-2.9%)
Mar 2021
-
$581.61 M(-7.2%)
Dec 2020
$627.01 M(-10.3%)
$627.01 M(-4.3%)
Sep 2020
-
$654.87 M(-1.2%)
Jun 2020
-
$663.01 M(+3.9%)
Mar 2020
-
$638.38 M(-8.7%)
Dec 2019
$699.13 M(+45.9%)
$699.13 M(+1.4%)
Sep 2019
-
$689.29 M(+77.2%)
Jun 2019
-
$388.91 M(-7.0%)
Mar 2019
-
$418.36 M(-12.7%)
Dec 2018
$479.08 M(+42.9%)
$479.08 M(+114.4%)
Sep 2018
-
$223.44 M(-15.6%)
Jun 2018
-
$264.72 M(-13.0%)
Mar 2018
-
$304.17 M(-9.3%)
Dec 2017
$335.29 M(-35.3%)
$335.29 M(-11.1%)
Sep 2017
-
$377.33 M(-9.1%)
Jun 2017
-
$415.14 M(-9.3%)
Mar 2017
-
$457.52 M(-11.7%)
Dec 2016
$518.41 M(+159.5%)
$518.41 M(-10.3%)
Sep 2016
-
$578.06 M(+41.4%)
Jun 2016
-
$408.81 M(-8.2%)
Mar 2016
-
$445.25 M(+122.9%)
Dec 2015
$199.76 M(-35.5%)
$199.76 M(-12.1%)
Sep 2015
-
$227.35 M(-11.1%)
Jun 2015
-
$255.82 M(-10.3%)
Mar 2015
-
$285.09 M(-7.9%)
Dec 2014
$309.49 M(+69.9%)
$309.49 M(-6.4%)
Sep 2014
-
$330.49 M(-5.6%)
Jun 2014
-
$350.11 M(-4.2%)
Mar 2014
-
$365.46 M(+100.7%)
DateAnnualQuarterly
Dec 2013
$182.13 M(+114.3%)
$182.13 M(+0.8%)
Sep 2013
-
$180.75 M(-0.4%)
Jun 2013
-
$181.47 M(+127.8%)
Mar 2013
-
$79.66 M(-6.3%)
Dec 2012
$84.98 M(+263.8%)
$84.98 M(+381.1%)
Sep 2012
-
$17.66 M(+39.0%)
Jun 2012
-
$12.71 M(-27.7%)
Mar 2012
-
$17.59 M(-24.7%)
Dec 2011
$23.36 M(-21.3%)
$23.36 M(-17.0%)
Sep 2011
-
$28.14 M(-14.3%)
Jun 2011
-
$32.82 M(-13.9%)
Mar 2011
-
$38.11 M(+28.4%)
Dec 2010
$29.69 M(+145.1%)
$29.69 M(<-9900.0%)
Sep 2010
-
-$174.00 K(-105.5%)
Jun 2010
-
$3.16 M(-55.5%)
Mar 2010
-
$7.10 M(-41.4%)
Dec 2009
$12.11 M(-77.1%)
$12.11 M(-36.1%)
Sep 2009
-
$18.97 M(-28.2%)
Jun 2009
-
$26.41 M(-31.2%)
Mar 2009
-
$38.39 M(-27.6%)
Dec 2008
$52.99 M(-53.5%)
$52.99 M(-20.0%)
Sep 2008
-
$66.24 M(-18.4%)
Jun 2008
-
$81.20 M(-17.7%)
Mar 2008
-
$98.67 M(-13.4%)
Dec 2007
$113.93 M(+69.6%)
$113.93 M(-12.2%)
Sep 2007
-
$129.73 M(-10.1%)
Jun 2007
-
$144.27 M(+154.0%)
Mar 2007
-
$56.80 M(-15.4%)
Dec 2006
$67.16 M(+70.6%)
$67.16 M(-14.3%)
Sep 2006
-
$78.40 M(-11.5%)
Jun 2006
-
$88.55 M(+122.1%)
Mar 2006
-
$39.86 M(+1.2%)
Dec 2005
$39.37 M(+28.3%)
$39.37 M(-20.0%)
Sep 2005
-
$49.20 M(-19.5%)
Jun 2005
-
$61.15 M(+88.9%)
Mar 2005
-
$32.37 M(+5.5%)
Dec 2004
$30.68 M(-158.2%)
$30.68 M(-17.9%)
Sep 2004
-
$37.36 M(-12.7%)
Jun 2004
-
$42.79 M(-173.3%)
Mar 2004
-
-$58.42 M(+10.9%)
Dec 2003
-$52.67 M(+31.4%)
-$52.67 M
Dec 2002
-$40.09 M(-324.4%)
-
Dec 2001
$17.86 M(-179.4%)
-
Dec 2000
-$22.51 M
-

FAQ

  • What is ACADIA Pharmaceuticals annual stockholders equity?
  • What is the all time high annual shareholders equity for ACADIA Pharmaceuticals?
  • What is ACADIA Pharmaceuticals annual shareholders equity year-on-year change?
  • What is ACADIA Pharmaceuticals quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for ACADIA Pharmaceuticals?
  • What is ACADIA Pharmaceuticals quarterly shareholders equity year-on-year change?

What is ACADIA Pharmaceuticals annual stockholders equity?

The current annual shareholders equity of ACAD is $431.75 M

What is the all time high annual shareholders equity for ACADIA Pharmaceuticals?

ACADIA Pharmaceuticals all-time high annual stockholders equity is $699.13 M

What is ACADIA Pharmaceuticals annual shareholders equity year-on-year change?

Over the past year, ACAD annual stockholders equity has changed by +$31.34 M (+7.83%)

What is ACADIA Pharmaceuticals quarterly stockholders equity?

The current quarterly shareholders equity of ACAD is $577.18 M

What is the all time high quarterly shareholders equity for ACADIA Pharmaceuticals?

ACADIA Pharmaceuticals all-time high quarterly stockholders equity is $699.13 M

What is ACADIA Pharmaceuticals quarterly shareholders equity year-on-year change?

Over the past year, ACAD quarterly stockholders equity has changed by +$215.01 M (+59.37%)